Prurigo Nodularis Epidemiology Forecast Report 2017-2030: Focus on United States, Germany, Spain, Italy, France, and United Kingdom, and Japan – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Prurigo Nodularis – Epidemiology Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering.
This report delivers an in-depth understanding of the disease, historical and forecasted Prurigo nodularis (PN) epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
Prurigo nodularis (PN) Epidemiology Perspective
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by diagnosed prevalence of prurigo nodularis, gender-specific diagnosed prevalence of prurigo nodularis, age-specific diagnosed prevalence of prurigo nodularis, type-specific prevalent population of prurigo nodularis, and severity-specific diagnosed prevalent population of prurigo nodularis in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom), and Japan from 2017 to 2030.
Prurigo nodularis (PN) Detailed Epidemiology Segmentation
- Prevalent population of Prurigo nodularis in 7MM is expected to increase at a CAGR of 0.63% for the study period, i.e., 2017-2030.
- Among the 7MM countries in 2017, the largest patient pool was accounted by the United States. On the other hand, Japan comprised the least number of cases affected by PN.
- EU comprised ~38% of the patient pool for PN in 2017.
- As per the publisher analysis, it has been observed that most of the patients with Prurigo nodularis diagnosed with atopic than non-Atopic.
- Estimates reveal that the overall diagnosed prevalence of PN follows an increasing trend with an increase in severity of the symptoms, such that moderate cases account for maximum diagnosed prevalent cases, followed by severe and mild cases.
Scope of the Report
- The report covers the descriptive overview of Prurigo nodularis (PN), explaining its causes, signs and symptoms, pathophysiology and currently available therapies.
- The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom) and Japan.
- The report assesses the disease risk and burden and highlights the unmet needs of Prurigo nodularis (PN).
- The report provides the segmentation of the disease epidemiology for 7MM by Total Prevalent Cases of Prurigo nodularis (PN), Total Diagnosed and TreatedCases of Prurigo nodularis (PN).
Report Highlights
- Eleven-Year Forecast of Prurigo nodularis (PN)
- 7MM Coverage
- Diagnosed Prevalence of Prurigo nodularis
- Gender-specific Diagnosed Prevalence of Prurigo nodularis
- Age-specific Diagnosed Prevalence of Prurigo nodularis
- Type-specific Prevalent Population of Prurigo nodularis
- Severity-specific Diagnosed Prevalent Population of Prurigo nodularis
Key Questions Answered
- What is the disease risk, burden and unmet needs of Prurigo nodularis (PN)?
- What is the historical Prurigo nodularis (PN) patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK) and Japan?
- What would be the forecasted patient pool of Prurigo nodularis (PN) at the 7MM level?
- What will be the growth opportunities across the 7MM with respect to the patient population pertaining to Prurigo nodularis (PN)?
- Out of the above-mentioned countries, which country would have the highest prevalent population of Prurigo nodularis (PN) during the forecast period (2020-2030)?
- At what CAGR the population is expected to grow across the 7MM during the forecast period (2020-2030)?
Key Topics Covered:
1 Key Insights
2 Prurigo nodularis (PN): Patient Overview at a Glance
2.1 Total Patient Share (%) Distribution of PN in 2017
2.2 Total Patient Share (%) Distribution of PN in 2030
3 Executive Summary
4 SWOT Analysis
5 Disease Background and Overview of Prurigo nodularis (PN)
5.1 Introduction
5.2 Classification
5.3 Clinical Signs and Symptoms
5.4 Pathophysiology
5.5 Etiology
5.5.1 Skin Disorders
5.5.2 Systemic Disorders
5.5.3 Psychiatric disorders
5.5.4 Associated Conditions
5.6 Diagnosis
5.7 Management
6 Recognized Establishments
7 Epidemiology and Patient Population: Prurigo nodularis (PN)
7.1 Key Findings
7.2 Epidemiology Methodology
7.3 KOL Views
7.4 7MM Total Diagnosed Prevalent Population of Prurigo nodularis
8 Country-wise Epidemiology of Prurigo nodularis
8.1 United States
8.1.1 Assumptions and Rationale
8.1.2 Diagnosed Prevalence of Prurigo nodularis in the United States
8.1.3 Gender-specific Diagnosed Prevalence of Prurigo nodularis in the United States
8.1.4 Age-specific Diagnosed Prevalence of Prurigo nodularis in the United States
8.1.5 Type-specific Diagnosed Prevalent Population of Prurigo nodularis in the United States
8.1.6 Severity-specific Diagnosed Prevalent Population of Prurigo nodularis in the United States
8.2 EU5 Countries
8.2.1 Assumptions and Rationale
8.3 Germany
8.4 France
8.5 Italy
8.6 Spain
8.7 United Kingdom
8.8 Japan
9 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/m3kzsj
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
